risks of glp-1 drugs nausea: How to handle GLP-1s' most common side effect Glucagon-like Receptor-1 agonists for obesity:

doi: 10.1007/S12020-023-03487-4 100 Austregsilo de Athayde De Hollanda MoraisBMartins PrizoVde Moura de SouzaMXimenes MendesBRodrigues DefanteMLCosendey MartinsOet al

For weight management , NHS eligibility is more restrictive

Weeks 17 onward: 12mg weekly maintenance for those in the highest arm

In a Phase 2 trial for T2D, weekly semaglutide was more effective at reducing HbA1c than daily liraglutide (NCT00696657)

Other contributing factors that could perhaps influence this relationship include the level of pre-existing retinopathy, initial hemoglobin A1c levels, duration of diabetes, cotreatment with insulin, and comorbidities

A recent meta-analysis encompassing 11 observational and case-control studies across various countries revealed no statistically significant disparity in suicidal outcomes between GLP-1 RA users and those utilizing alternative antihyperglycemic medications (relative risk, 0.57